NOVO — Maj 2025
-
Danske udbytte-aristokrater - To danske virksomheder, der kan prale af 25+ aar med stigende udbytte er Novo Nordisk og Coloplast. https://proinvestor.com/boards/126481/
-
Novo Nordisk, the Danish pharmaceutical company behind popular semaglutide medications Ozempic, Wegovy and Rybelsus, filed the complaint Wednesday in U.S. District Court in Youngstown. The lawsuit names Amble Health Inc., an Ohio corporation with a registered business address in Southington. https://www.wfmj.com/story/52795146/weightloss-drug-giant-sues-ohio-firm-in-youngstown-court?utm_source=substack&utm_medium=email
-
NOVOs problemer er mangfoldige og har været kendt af nogle. https://proinvestor.com/boards/126496
-
Novo Nordisk har lavet en stor obligationsudstedelse. Det øger dog næppe sandsynligheden for et aktietilbagekøb https://proinvestor.com/boards/126506/
-
Novo Nordisks rekordlån øger håb om aktietilbagekøb blandt investorer https://proinvestor.com/investornyt/1321150/novo-nordisks-rekordlan-oger-hab-om-aktietilbagekob-blandt-investorer
-
En datalje : Hvis Apple skal - som Trump siger - betale told af de telefoner der produceres i udlandet og importeres til USA, er det vel nærliggende at tro at Lilly ryger i toldfælden med deres produkter fra Irland. Det bliver spændende at følge og da en klar fordel for Novo, der jo netop producerer alt hvad sælger derovre i USA. Har nogle en mening om det,eller er jeg bare bagud i opdateringen?
-
Tak JKY...Jeg har lagt begge udlægninger i tråden 11,47.
-
koden: Ja netop..jeg mener jo så at novo er fritaget for told, og at lilly er i problemer med netop tolden, da de jo producerer vildt meget i Irland,altså EU. Det må da give Novo en klar prisfordel,selvom prisen jo bliver lobbet op af grossistleddet.Men jeg har måske overset en detalje....
-
Novo Nordisk should be thinking about 'what's next,' says Dr. Kavita Patel
Video: https://proinvestor.com/boards/126544 -
Novo leder efter ny topchef med danske værdier og amerikansk forretningssans https://proinvestor.com/investornyt/1321256/novo-leder-efter-ny-topchef-med-danske-vaerdier-og-amerikansk-forretningssans
-
-
GLP-1 Receptor Agonists May Modestly Reduce Risk of Fourteen Obesity-Related Cancers for People with Diabetes https://www.asco.org/about-asco/press-center/news-releases/glp-1-receptor-agonists-may-modestly-reduce-risk-obesity-related-cancers-people-with-diabetes
-
Aktier/tendens: Novo, DSV og Zealand kan rammes af ny vægtning i ventet flad åbning https://proinvestor.com/investornyt/1321376/aktier-tendens-novo-dsv-og-zealand-kan-rammes-af-ny-vaegtning-i-ventet-flad-abning
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind